---
document_datetime: 2025-09-16 17:16:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/riulvy-epar-all-authorised-presentations_en.pdf
document_name: riulvy-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1854852
conversion_datetime: 2025-12-14 15:56:30.079125
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form            | Route of Administration   | Immediate Packaging       | Pack size             |
|------------------|-------------------|------------|--------------------------------|---------------------------|---------------------------|-----------------------|
| EU/1/25/1947/001 | RIULVY            | 174 mg     | Gastro-resistant capsule, hard | Oral use                  | blister (OPA/alu/PVC-alu) | 14 capsules           |
| EU/1/25/1947/002 | RIULVY            | 174 mg     | Gastro-resistant capsule, hard | Oral use                  | bottle (HDPE)             | 14 capsules           |
| EU/1/25/1947/003 | RIULVY            | 348 mg     | Gastro-resistant capsule, hard | Oral use                  | blister (OPA/alu/PVC-alu) | 56 capsules           |
| EU/1/25/1947/004 | RIULVY            | 348 mg     | Gastro-resistant capsule, hard | Oral use                  | bottle (HDPE)             | 56 capsules           |
| EU/1/25/1947/005 | RIULVY            | 348 mg     | Gastro-resistant capsule, hard | Oral use                  | bottle (HDPE)             | 168 (3 x 56) capsules |